Levosalbutamol
Levosalbutamol is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target beta-2 adrenergic receptor.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
1048 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Colorectal neoplasms | D015179 | 59 | 206 | 112 | 3 | 9 | 358 | ||
| Stomach neoplasms | D013274 | EFO_0003897 | C16 | 19 | 60 | 15 | 2 | 5 | 92 |
| Adenocarcinoma | D000230 | 13 | 35 | 16 | 1 | 1 | 57 | ||
| Toxoplasmosis | D014123 | EFO_0007517 | B58 | 1 | — | — | 1 | — | 2 |
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 44 | 65 | 15 | — | 2 | 106 |
| Neoplasms | D009369 | C80 | 54 | 31 | 12 | — | — | 90 | |
| Rectal neoplasms | D012004 | 18 | 40 | 12 | — | 1 | 66 | ||
| Colonic neoplasms | D003110 | C18 | 13 | 22 | 16 | — | 2 | 47 | |
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | C91.0 | 11 | 23 | 16 | — | 2 | 44 | |
| Lymphoma | D008223 | C85.9 | 7 | 24 | 10 | — | 4 | 44 | |
| Esophageal neoplasms | D004938 | C15 | 10 | 30 | 5 | — | 1 | 40 | |
| Leukemia | D007938 | C95 | 3 | 23 | 11 | — | 2 | 39 | |
| Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 7 | 13 | 7 | — | 4 | 29 |
| Hiv infections | D015658 | EFO_0000764 | B20 | 5 | 2 | 8 | — | 8 | 23 |
Show 39 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Renal cell carcinoma | D002292 | 8 | 6 | — | — | — | 12 | ||
| Myelodysplastic syndromes | D009190 | D46 | 7 | 4 | — | — | — | 10 | |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 7 | 5 | — | — | — | 10 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 4 | 4 | — | — | — | 8 |
| Sarcoma | D012509 | 3 | 5 | — | — | — | 8 | ||
| Osteosarcoma | D012516 | 3 | 4 | — | — | 2 | 8 | ||
| Myeloid leukemia acute | D015470 | C92.0 | 7 | 1 | — | — | — | 7 | |
| Non-small-cell lung carcinoma | D002289 | 7 | 2 | — | — | — | 7 | ||
| Melanoma | D008545 | 6 | 3 | — | — | — | 7 | ||
| Triple negative breast neoplasms | D064726 | 5 | 4 | — | — | — | 6 |
Show 65 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Fallopian tube neoplasms | D005185 | 3 | — | — | — | — | 3 | ||
| Gastrointestinal stromal tumors | D046152 | EFO_0000505 | C49.A | 3 | — | — | — | — | 3 |
| Prostatic neoplasms | D011471 | C61 | 2 | — | — | — | — | 2 | |
| Hepatitis c | D006526 | B19.2 | 2 | — | — | — | — | 2 | |
| Healthy volunteers/patients | — | 2 | — | — | — | — | 2 | ||
| Hematologic neoplasms | D019337 | 1 | — | — | — | — | 1 | ||
| Primary myelofibrosis | D055728 | D47.4 | 1 | — | — | — | — | 1 | |
| B-cell chronic lymphocytic leukemia | D015451 | C91.1 | 1 | — | — | — | — | 1 | |
| Anemia | D000740 | EFO_0004272 | D64.9 | 1 | — | — | — | — | 1 |
| Leukemia myeloid chronic atypical bcr-abl negative | D054438 | C92.2 | 1 | — | — | — | — | 1 |
Show 15 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Invasive hydatidiform mole | D002820 | D39.2 | — | — | — | — | 1 | 1 | |
| Juvenile arthritis | D001171 | EFO_0002609 | M08 | — | — | — | — | 1 | 1 |
| Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | — | 1 | 1 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | — | — | — | 1 | 1 |
| Appetitive behavior | D001070 | — | — | — | — | 1 | 1 | ||
| Healthy diet | D000072001 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | LEVOSALBUTAMOL |
| INN | levosalbutamol |
| Description | (R)-salbutamol is an albuterol. |
| Classification | Small molecule |
| Drug class | anti-inflammatory agents (salicylic acid derivatives) |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1 |
Identifiers
| PDB | — |
| CAS-ID | 34391-04-3 |
| RxCUI | 237159 |
| ChEMBL ID | CHEMBL1002 |
| ChEBI ID | 8746 |
| PubChem CID | 123600 |
| DrugBank | DB13139 |
| UNII ID | EDN2NBH5SS (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
ADRB2
ADRB2
Organism
Homo sapiens
Gene name
ADRB2
Gene synonyms
ADRB2R, B2AR
NCBI Gene ID
Protein name
beta-2 adrenergic receptor
Protein synonyms
adrenergic, beta-2-, receptor, surface, adrenoceptor beta 2 surface, Beta-2 adrenoceptor, Beta-2 adrenoreceptor, catecholamine receptor
Uniprot ID
Mouse ortholog
Adrb2 (11555)
beta-2 adrenergic receptor (Q8BH38)
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 132 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
29,028 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more